Tag Archives: operation warp speed

Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab to the U.S. government under a potential $2.63B agreement with the departments of Defense and Health and Human Services.

Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus.

Pfizer has entered into an agreement with the departments of Health and Human Services and Defense to provide 100M more doses of the messenger RNA-based COVID-19 vaccine that the company developed with pharmaceutical firm BioNTech.

Merck (NYSE: MRK) has reached a $356M deal with the departments of Defense and Health and Human Services to further develop and seek regulatory approval MK-7110, the biopharmaceutical firm's investigational drug for hospitalized COVID-19 patients.

Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and Human Services to initially supply 300K doses of bamlanivimab, an investigational monoclonal antibody drug for COVID-19.

AstraZeneca has secured a $486M contract from the departments of Health and Human Services and Defense to further develop and test a pair of monoclonal antibodies as potential COVID-19 treatment. The company will use the funds to conduct large-scale production and Phase 3 trials of the experimental AZD7442 combo drug to help prevent or treat SARS-CoV-2 infections, HHS said Friday.

Ology Bioservices has won a one-year, $106.3M reserve production capacity contract from the U.S. Army Contracting Command for more than 186M doses of COVID-19 vaccines and other treatments to support the Trump administration's Operation Warp Speed.

The Centers for Disease Control and Prevention will move to exercise an option under a 2016 contract with Irving, Texas-based health care company McKesson (NYSE: MCK) for the distribution of vaccines and associated supplies intended for pandemic vaccination efforts.

The departments of Health and Human Services and Defense have signed a potential $1.5B agreement with Moderna to produce 100M doses of its COVID-19 vaccine candidate as part of the U.S. government’s Operation Warp Speed.

Johnson & Johnson (NYSE: JNJ) has received $1B in U.S. government funding for large-scale production of a potential COVID-19 vaccine as part of the White House’s Operation Warp Speed.